Yousefian, S., Schubert, ML., Minafra, A.R. et al. A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.
Nat Commun 17, 7589 (2026). https://doi.org/10.1038/s41467-026-76068-4
https://doi.org/10.1038/s41467-026-76068-4
Tags: cancer immunotherapy mechanismsCAR-T Cell Therapycellular therapy optimizationdistinct CAR-T cell phenotypesdose-dependent CAR-T cell efficacyimmune cell phenotypic profilesimmunotherapy for cancerNat Communications cancer researchpersonalized cancer treatmentT cell engineeringtherapeutic response at limited doses
